marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-18-2024
Cellectar Biosciences Financial Ratios 2011-2024 | CLRB
Annual Financial Ratios Cellectar Biosciences
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-1.0 | -0.4 | -0.1 | -1.7 | -1.4 | -0.5 | -1.3 | -1.2 | -0.8 | -1.4 | -2.1 | -3.3 | -1.3 |
P/S |
- | - | - | - | - | - | - | - | - | - | - | - | - |
EPS |
-3.5 | -4.5 | -4.3 | -0.8 | -1.8 | -5.2 | -1.1 | -1.4 | -7.0 | -1.8 | -0.2 | -0.2 | -0.3 |
EV (Enterprise Value) |
60.8 M | 4.11 M | -28.2 M | -30.7 M | 12.9 M | -5.48 M | 9.51 M | -2.49 M | 6.39 M | 4.27 M | 25.5 M | 25.8 M | 5.58 M |
EBITDA per Share |
-3.17 | -4.06 | -4.32 | -1.1 | -1.83 | -3.91 | -8.59 | -20 | -105 | -203 | -363 | -413 | -571 |
EV/EBITDA |
1.3 | 2.0 | -0.7 | 0.6 | -0.6 | 0.5 | -0.1 | -0.2 | -2.0 | -3.0 | -0.8 | ||
PEG |
-0.03 | -0.01 | -0.01 | -0.04 | -0.02 | -0.01 | -0.06 | -0.01 | -0.01 | -0.03 | 0.0 | 0.01 | 0.0 |
P/B |
-3.2 | 1.3 | 0.1 | 0.5 | 2.2 | 0.5 | 1.6 | 0.5 | 2.6 | 1.0 | 13.4 | 2.9 | 1.1 |
P/CF |
-1.4 | -0.5 | -0.1 | -420.3 | -1.7 | -0.5 | -1.5 | -0.9 | -0.5 | -1.2 | -2.5 | -4.4 | -1.6 |
ROE % |
282.15 | -389.94 | -73.00 | -27.55 | -155.56 | -99.83 | -126.11 | -45.65 | -333.07 | -75.44 | -634.12 | -86.61 | -78.48 |
ROA % |
-354.19 | -147.26 | -64.84 | -25.73 | -115.04 | -87.94 | -105.37 | -40.33 | -72.34 | -60.41 | -158.06 | -76.66 | -70.45 |
ROCE % |
257.01 | -353.40 | -73.03 | -27.75 | -149.55 | -86.77 | -126.44 | -69.02 | -451.81 | -86.06 | -468.70 | -81.86 | -73.96 |
Current Ratio |
0.5 | 1.8 | 8.9 | 16.3 | 4.1 | 8.6 | 5.2 | 7.5 | 0.7 | 4.4 | 0.6 | 7.0 | 11.6 |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Cellectar Biosciences
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.37 | -0.03 | -0.74 | - | -1.55 | -0.9 | -0.76 | - | -1.28 | -1.22 | -1 | - | -0.97 | -0.11 | -0.13 | - | -0.15 | -0.26 | -0.42 | - | -0.42 | -0.46 | -0.76 | - | -1.65 | -1.69 | -2.07 | - | -2.58 | -2.32 | -0.24 | - | -0.43 | -0.49 | 0.96 | - | -2.46 | -3.02 | -3.04 | - | 0.06 | -0.73 | -1.03 | - | -0.46 | -0.72 | -0.07 | - | -0.06 | -0.06 | -0.06 | - | -0.07 | -0.1 | -0.08 |
EBITDA per Share |
- | - | -0.41 | - | - | - | -0.77 | - | -1.26 | -1.22 | -1 | - | -0.95 | -0.11 | -0.13 | - | -0.14 | -0.26 | -0.42 | - | -0.41 | -0.45 | -0.75 | - | -0.95 | -1.66 | -2.04 | - | -2.37 | -2.25 | -0.23 | - | -0.41 | -0.5 | -2.23 | - | -2.41 | -2.79 | -3.3 | - | -0.4 | -0.82 | -0.95 | - | -0.9 | -0.87 | -0.05 | - | -0.04 | -0.05 | -0.06 | - | -0.05 | -0.08 | -0.02 |
ROE % |
-124.03 | 35.24 | 164.01 | 66.92 | 5.66 | -118.18 | -276.34 | -120.65 | -135.73 | -89.55 | -66.43 | -41.56 | -48.69 | -40.75 | -33.63 | -20.95 | -64.04 | -100.00 | -128.59 | -118.25 | -140.99 | -120.63 | -107.47 | -70.97 | -103.24 | -112.78 | -119.78 | -88.18 | -105.07 | -89.69 | -76.42 | -26.55 | -139.19 | -234.93 | -357.77 | -390.71 | -385.87 | -268.40 | -160.95 | -70.25 | -147.65 | -229.88 | -320.20 | -402.09 | -422.29 | -365.10 | -265.59 | -65.36 | -85.50 | -85.43 | -90.84 | -57.69 | -20.14 | -27.37 | -10.18 |
ROA % |
-174.05 | -216.02 | -369.27 | -295.50 | -335.94 | -295.07 | -157.89 | -78.82 | -92.69 | -46.93 | -59.56 | -38.04 | -44.71 | -37.50 | -31.03 | -19.57 | -51.43 | -76.64 | -96.50 | -87.45 | -107.47 | -95.64 | -89.02 | -62.52 | -89.48 | -96.42 | -101.27 | -73.68 | -88.60 | -76.56 | -66.23 | -23.46 | -47.92 | -57.46 | -73.64 | -84.86 | -82.44 | -55.56 | -41.01 | -35.06 | -54.36 | -76.07 | -90.82 | -100.26 | -118.14 | -116.72 | -105.87 | -57.85 | -75.92 | -76.11 | -81.25 | -51.78 | -18.07 | -24.57 | -9.14 |
ROCE % |
- | - | - | - | -61.30 | -122.59 | -159.41 | -120.68 | -135.77 | -89.55 | -66.44 | -41.57 | -48.63 | -40.62 | -33.46 | -20.79 | -62.60 | -97.34 | -124.55 | -113.85 | -136.83 | -118.01 | -105.88 | -70.32 | -102.71 | -112.11 | -120.39 | -88.43 | -106.46 | -92.10 | -79.23 | -49.68 | -160.20 | -252.69 | -356.66 | -368.19 | -399.82 | -320.93 | -235.34 | -106.28 | -233.22 | -328.53 | -411.85 | -363.98 | -383.10 | -275.27 | -177.11 | -61.34 | -80.34 | -80.22 | -82.05 | -49.89 | -19.00 | -22.41 | -8.49 |
Current Ratio |
1.8 | 1.9 | 2.6 | 0.5 | 1.3 | 0.9 | 2.0 | 3.5 | 2.9 | - | 6.7 | 8.9 | 12.5 | 12.7 | 10.4 | 15.2 | 15.2 | 15.2 | 15.2 | 3.8 | 3.8 | 3.8 | 3.8 | 8.4 | 8.4 | 8.4 | 8.4 | 6.1 | 6.1 | 6.1 | 6.1 | 8.6 | 8.6 | 8.6 | 8.6 | 1.3 | 1.3 | 1.3 | 1.3 | 2.0 | 2.0 | 2.0 | 2.0 | 1.3 | 1.3 | 1.3 | 1.3 | 8.7 | 8.7 | 8.7 | 8.7 | 9.8 | - | 9.8 | 9.8 |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency